Submitted by Anonymous (not verified) on 17 December 2025 - 15:16
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 25, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 25, Status: Authorised